Save
Busy. Please wait.
Log in with Clever
or

show password
Forgot Password?

Don't have an account?  Sign up 
Sign up using Clever
or

Username is available taken
show password


Make sure to remember your password. If you forget it there is no way for StudyStack to send you a reset link. You would need to create a new account.
Your email address is only used to allow you to reset your password. See our Privacy Policy and Terms of Service.


Already a StudyStack user? Log In

Reset Password
Enter the associated with your account, and we'll email you a link to reset your password.
focusNode
Didn't know it?
click below
 
Knew it?
click below
Don't Know
Remaining cards (0)
Know
0:00
Embed Code - If you would like this activity on your web page, copy the script below and paste it into your web page.

  Normal Size     Small Size show me how

AnticancerDrugs

lecture 5-6 goodman

QuestionAnswer
2 most important checkpoint controls in the cell cycle G1-S checkpoint and the G2-M checkpoint
ca with shorter doubling time = easier to cure leukemias respond better to anti-ca tx than colon carcinomas, which have a larger doubling time
types of normal cells that might be killed with chemotx hair follicle cells, colonic crypts and bone marrow
antimetabolites kill cells that are in ___ phase during exposure S phase
vinca alkaloids kill cells that are in ____ phase during drug exposure M phase
phase non-specific drugs kill cycling cells regardless of the phase they are in during exposure; cells will actually be killed in the S PHASE thus they are GROWTH-DEPENDENT drugs
first-order cell killing or logarithmic kill when giving a dose of chemotx, 99% of cells will be killed with each round, fixed percentage die
What area of tumor has the slowest growing cells? cells further away from the surface of the tumor aka in the core
Why use multi-drug therapy? tumor cells can develop resistance by inducing production of a multi-drug resistance pump, for example, or duplicating genes like the DHFR gene
typical toxicities of anti-ca tx GI: mucositis, nausea, cells dying in intestinal crypts // Heme: anemia, bleeding, myelosupression (give erythropoietin) // Hair: follicular cells die, hair falls out
types of drugs that interfere with DNA antimetabolites, alkylating drugs, those which interrupt with topoisomerases
antimetabolite class interfere with synthesis of normal nucleic acids; work as triphosphonucleotides to inhibit DNA polymerase or cause chain termination
purine analogs mercaptopurine (hypoxanthine) and thioguanine (guanine) are analogs that work to deplete cells of purine nucleotides
5-FU S PHASE DRUG - activated to 5-FdUMP, which inhibits thymidylate synthase and starves cells of thymidine. resistance by altering TSase, causes myelosuppression and hair loss
capecitabine prodrug that is metabolized to 5-FU in cells, ORAL DRUG
cytarabine S PHASE DRUG, block btwn G1 and S - cytosine analog with arabinose instead of ribose, inhibits chain elongation, resistance by more cytidine deaminase. BEST tx for AML
methotrexate S PHASE DRUG - analog of folic acid that binds with very high affinity to DHFR, depletes building blocks for DNA & RNA synthesis. use for leukemias & choriocarcinoma, resistance by upregulating salvage pathways
drug given to "rescue" pt after high doses of methotrexate leucovorin - fully reduced folate coenzyme that helps to restore folic acid precursors in cells
hydroxyurea erythrosuppressive that inhibits ribonucleoside reductase, useful for leukemias and lymphomas. also for sickle cell crises, very toxic
alkylating agents cyclize to generate positively charged reactive intermediates that can be attacked by lone pairs of electrons on N or O of DNA forming crosslinked strands; cells enter S phase with damaged DNA and die
prototype of alkylating agents mechlorethamine
cyclophosphamide useful oral alkylating agent, is inactive until first pass through liver, can cause hemorrhagic cystitis
anthracyclines planar tetracycline ring that intercalates btwn stacks of bases in DNA, reduced within cells and makes ROS, interferes with topoisomerase type II
adverse effects of alkylating agents severe bone marrow suppression with high tendency for development of leukemias and lymphomas yrs later, mucositis, possible bacterial sepsis, amenorrhea and azoospermia
platinum complexes non-classical alkylators that crosslink DNA, bifunctional agents that can react with guanines on same or different DNA strands; good use for solid tumors like testicles or ovaries
cisplatin platinum complex; administered IV and is very nephrotoxic if not hydrated, ototoxicity and peripheral neuropathy, myelosuppression
unique adverse effect of anthracyclines cardiomyopathy that is usually irreversible, occurs in up to 33% of pts taking these drugs
doxorubicin (Adriamycin) anthracycline that treats wide range of tumors
bleomycin G2 SPECIFIC DRUG: mixture of drugs that are complex glycopeptide antibiotics, chelate iron and copper and bind to DNA leading to redox radicals that cause multiple strand breaks and chr aberrations
adverse reactions of bleomycin pulmonary fibrosis (Lance Armstrong didn't want to take it), one of the few drugs that is NOT TOXIC TO BONE MARROW
anti-topoisomerase agents irinotecan (binds topo I, DS breaks during S phase metabolized to active drug SN-38, eliminated by glucuronidation) // etoposide (inhibits topo II causing DNA breaks)
antimicrotubule agents act on microtubules to block cell progression through mitosis --- classes are taxanes and vinca alkaloids
vincristine and vinblastine M PHASE AGENTS: bind tubulin alpha-beta heterodimers that stop formation of microtubules, cuase myelosuppression and neurotoxicity. vinblastine best for testicular ca, solid tumors
vincristine primarily for childhood leukemias and lymphomas, worst side effect is peripheral neuropathy that can cause paresthesias or anesthesias
paclitaxel (Taxol) binds preferentially to beta tubulin of existing microtubules and stops their disassembly, inhibits mitosis, good for breast and ovarian ca. can cause neuropathy
prednisone synthetic glucocorticoid used for tx of leukemia
tamoxifen SERM or selective estrogen receptor modulator; binds competitively with estrogen on ER+ breast ca cells; approved for prophylaxis of ER-sensitive breast ca in women with BRCA1 or 2 gene mutations
how to reduce the endogenous sex steroid production when treating hormone-sensitive breast or prostate ca oophorectomy/orchiectomy and treatment with a GnRH analog
anastrozole aromatase inhibitor that stops peripheral estradiol production from adipose tissue to as to starve the hormone-sensitive breast ca
flutamide anti-androgen used in combo with GnRH agonist to safely cause a chemical castration for tx of prostate ca
leuprolide potent GnRH agonist, causes a transient release of FSH and LH then strong feedback inhibition, resulting in cessation of testosterone production
drugs ending in -inib small molecules that INhIBit tyrosine kinases
drugs ending in -umab hUManized ABs that are altered genetically so as not to produce an anti-mouse neutralization response
drugs ending in -ximab "X out the mouse Ab", drugs that are chimerized to contain human Fc region
imatinib (Gleevec) specific inhibitor of bcr-abl oncogene for tx of chronic myelogenous leukemia (CML)
bevacizumab (Avastin) monoclonal Ab against VEGF, inactivates it and solid tumors fail to grow due to insufficient vascularization. side effects include slow wound healing and increased bleeding
interleukin-2 stimulates the generation of killer T cells that attack malignant metastatic melanoma and other leukemias
thalidomide downregulates IL-6, VEGF and TNF synthesis, important in the tx of multiple myeloma. also now for leprosy and MS
bortezomib inhibits the proteasome that would normally destroy IkappaB and free it from NFkappaB so it can promote growth genes within the nucleus
Tretinoin is ATRA that binds to RAR, which dimerizes with RXR to displace a transcription inhibitor and promote differentiation of myeloid precursors; first line tx for acute promyelocytic leukemia (APL); ATRA syndrome - pulmonary infiltration and resp distress
colony stimulating factors inreases the # of nl blood cells, allowing more aggressive use of cytotoxic agents with fewer effects on bone marrow cells; include erythropoietin, granulocyte CSF and granulocyte-macrophage CSF
Created by: sirprakes
Popular Pharmacology sets

 

 



Voices

Use these flashcards to help memorize information. Look at the large card and try to recall what is on the other side. Then click the card to flip it. If you knew the answer, click the green Know box. Otherwise, click the red Don't know box.

When you've placed seven or more cards in the Don't know box, click "retry" to try those cards again.

If you've accidentally put the card in the wrong box, just click on the card to take it out of the box.

You can also use your keyboard to move the cards as follows:

If you are logged in to your account, this website will remember which cards you know and don't know so that they are in the same box the next time you log in.

When you need a break, try one of the other activities listed below the flashcards like Matching, Snowman, or Hungry Bug. Although it may feel like you're playing a game, your brain is still making more connections with the information to help you out.

To see how well you know the information, try the Quiz or Test activity.

Pass complete!
"Know" box contains:
Time elapsed:
Retries:
restart all cards